Filing Details
VERACYTE, INC. (NASDAQ:VCYT) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 05, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:VCYT
VERACYTE, INC. (VCYT) Files Quarterly Report for Q0
VERACYTE, INC. (NASDAQ:VCYT) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 05, 2026.
At publication ·
What changed
VERACYTE, INC. (NASDAQ:VCYT) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Veracyte filed its quarterly 10-Q report on November 5, 2026, providing unaudited financial statements and management updates.
- The company's stock trades at $52.52 with a market capitalization of $3.3 billion.
- The article contains no reported revenue figures or specific financial performance metrics for the quarter.
Market Context
VERACYTE, INC.'s stock currently trades at $52.52 with a market capitalization of $3.3B.
The 10-Q provides VERACYTE, INC.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for VERACYTE, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View VCYT Stock Page
Frequently Asked Questions
Where can I read VCYT's SEC filings?
Browse all filings on our VCYT SEC filings page.
What types of SEC filings does VERACYTE, INC. file?
Public companies like VERACYTE, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.